Mercoledì - Auditorium - Current management of immune-related adverse events Michel Obeid, CH Responsable Centre des toxicités en immuno-oncologie de Lausanne LCIT, Service immunologie et allergie, CHUV, Lausanne
Mercoledì - Auditorium - Successful public-private partnerships between academia and pharma Verena Voelter, US CEO & Founder 5P Health Care Solutions AG, Author ‘It Takes 5 to Tango: from Competition to Cooperation in Health Care’
Mercoledì - Auditorium - Artificial intelligence applied in oncology Jakob Nikolas Kather, DE Professor of Clinical Artificial Intelligence, Else Kröner Fresenius Center for Digital Health, Technical University Dresden